Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 2
1954 1
1959 1
1963 1
1990 1
1992 42
1993 113
1994 190
1995 155
1996 154
1997 228
1998 200
1999 204
2000 219
2001 326
2002 339
2003 374
2004 443
2005 480
2006 486
2007 540
2008 548
2009 572
2010 532
2011 618
2012 696
2013 858
2014 992
2015 972
2016 913
2017 988
2018 934
2019 421
2020 7
Text availability
Article attribute
Article type
Publication date

Search Results

12,199 results
Results by year
Filters applied: . Clear all
Page 1
Cost-of-illness studies: concepts, scopes, and methods.
Jo C. Clin Mol Hepatol 2014 - Review. PMID 25548737 Free PMC article.
The cost-of-illness study is considered to be an essential evaluation technique in health care. By measuring and comparing the economic burdens of diseases to society, such studies can help health-care decision-makers to set up and prioritize health-care policies and interventions. ...By discussing the epidemiological and economic grounds of the cost-of-illness study, the reported results represent useful information about several evaluation techniques at an advanced level, such as cost-benefit analysis, cost-effectiveness analysis, and cost-utility analysis....
The cost-of-illness study is considered to be an essential evaluation technique in health care. By measuring and comparing the …
A Systematic Review of Cost-of-Illness Studies of Multimorbidity.
Wang L, et al. Appl Health Econ Health Policy 2018 - Review. PMID 28856585
This review analyzed the methods of cost-of-illness (COI) studies and summarized the economic outcomes of multimorbidity. METHODS: A systematic review (2000-2016) was performed, which was registered with Prospero, reported according to PRISMA, and used a quality checklist adapted for COI studies. ...Synthesising the cost of multimorbidity was challenging due to multiple definitions of multimorbidity and heterogeneity in COI methods. ...
This review analyzed the methods of cost-of-illness (COI) studies and summarized the economic outcomes of multimorbidity. METH …
Cost-of-illness of patients with lymphoedema.
Gutknecht M, et al. J Eur Acad Dermatol Venereol 2017. PMID 28662302
OBJECTIVE: The aim of this study was to determine the costs of illness of community lymphoedema patients living in the metropolitan area of Hamburg, Germany. ...This community-based study is the first cost analysis of chronic lymphoedema and combined lipolymphoedema giving insights to economic impact of lymphoedema treatment. ...
OBJECTIVE: The aim of this study was to determine the costs of illness of community lymphoedema patients living in the metropolitan a …
Cost of illness of leukemia in Japan - Trend analysis and future projections.
Amin R, et al. J Chin Med Assoc 2018. PMID 29929830 Free article.
The objective of this study was to analyze the cost of illness (COI) of leukemia, and to mark out the underlying driving factors, in Japan. ...Mortality cost per person also decreased, however, the percentage of mortality cost for individuals ≥65 years of age increased consistently from 1996 to 2014. ...
The objective of this study was to analyze the cost of illness (COI) of leukemia, and to mark out the underlying driving facto …
The cost and burden of cancer in the European Union 1995-2014.
Jönsson B, et al. Eur J Cancer 2016. PMID 27589247
BACKGROUND: There is an intense debate about the cost of cancer and the value of new treatments. However, there is limited data on the cost of cancer in the European Union (EU) and how costs relate to the burden of disease. This paper presents new estimates on the development of the cost of cancer in the EU 1995-2014, with a focus on the major cost components: total health expenditure, cancer drugs, and production loss due to premature mortality. ...
BACKGROUND: There is an intense debate about the cost of cancer and the value of new treatments. However, there is limited data on th …
Cost of Illness for Five Major Foodborne Illnesses and Sequelae in Sweden.
Sundström K. Appl Health Econ Health Policy 2018. PMID 29313242 Free PMC article.
These estimates provide a necessary contribution to perform future cost-benefit analyses aimed at reducing the burden of foodborne disease. ...The total cost for the five pathogens (including sequelae) amounted to €142 million annually. Campylobacter was the most costly pathogen, representing 69% of the total costs. ...
These estimates provide a necessary contribution to perform future cost-benefit analyses aimed at reducing the burden of foodborne di …
Cost-of-illness studies in nine Central and Eastern European countries.
Brodszky V, et al. Eur J Health Econ 2019. PMID 31104219 Free PMC article.
BACKGROUND: To date, a multi-country review evaluating the cost-of-illness (COI) studies from the Central and Eastern European (CEE) region has not yet been published. ...CONCLUSIONS: Cost-of-illness studies varied considerably in terms of methodology, publication practice, and clinical areas. Due to these heterogeneities, transferability of the COI results is limited across Central and Eastern European countries....
BACKGROUND: To date, a multi-country review evaluating the cost-of-illness (COI) studies from the Central and Eastern European …
Patient Attitudes Regarding the Cost of Illness in Cancer Care.
Meisenberg BR, et al. Oncologist 2015. PMID 26330457 Free PMC article.
BACKGROUND AND PURPOSE: The cost of illness in cancer care and the subsequent distress has attracted scrutiny. Guidelines recommend enhanced discussion of costs, assuming this will reduce both stress and costs. ...Even when asked to assume that lower cost regimens were equally effective, only 28% would definitely want the lower cost regimen. ...
BACKGROUND AND PURPOSE: The cost of illness in cancer care and the subsequent distress has attracted scrutiny. Guidelines reco …
Cost-of-illness studies for bipolar disorder: systematic review of international studies.
Jin H and McCrone P. Pharmacoeconomics 2015 - Review. PMID 25576148
Cost-of-illness (COI) studies provide useful information on the economic burden that BD imposes on a society. Furthermore, COI studies are pivotal sources of evidence used in economic evaluations. ...The primary outcome of this review was the annual cost per BD patient. A narrative assessment of key methodological issues was also included. ...
Cost-of-illness (COI) studies provide useful information on the economic burden that BD imposes on a society. Furthermore, COI
12,199 results
Jump to page
Feedback